CN106190993A - Avian influenza vaccine and the diagnostic antigen preparation method planting poison used - Google Patents

Avian influenza vaccine and the diagnostic antigen preparation method planting poison used Download PDF

Info

Publication number
CN106190993A
CN106190993A CN201510502806.5A CN201510502806A CN106190993A CN 106190993 A CN106190993 A CN 106190993A CN 201510502806 A CN201510502806 A CN 201510502806A CN 106190993 A CN106190993 A CN 106190993A
Authority
CN
China
Prior art keywords
avian influenza
virus
vaccine
influenza vaccine
diagnostic antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510502806.5A
Other languages
Chinese (zh)
Inventor
蒋文明
陈继明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHINA ANIMAL HEALTH AND EPIDEMIOLOGY CENTER
Original Assignee
CHINA ANIMAL HEALTH AND EPIDEMIOLOGY CENTER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHINA ANIMAL HEALTH AND EPIDEMIOLOGY CENTER filed Critical CHINA ANIMAL HEALTH AND EPIDEMIOLOGY CENTER
Publication of CN106190993A publication Critical patent/CN106190993A/en
Pending legal-status Critical Current

Links

Abstract

The present invention relates to veterinary biological product field, be used for preparing avian influenza vaccine and diagnostic antigen required kind poison.Present invention application Reverse Genetics, six, inside gene (PB2 with influenza virus cold adaptation strain, PB1, PA, NP, M, NS) it is genome skeleton, together with bird flu virus HA and NA gene, artificial constructed influenza virus, this virus is as preparing avian influenza vaccine and diagnostic antigen required kind poison, there is higher safety, and keep titer high, the advantages such as matching is strong, attenuated vaccine or the inactivated vaccine of preparation are safe and reliable, stronger immunity can be produced after immunity, can preventing bird flu effectively popular and propagating, reduce the economic loss that primary disease causes, reduce the threat to human health, there is important public health meaning, have broad application prospects.

Description

Avian influenza vaccine and the diagnostic antigen preparation method planting poison used
Technical field
The present invention relates to avian influenza vaccine and the diagnostic antigen preparation method planting poison used, belong to biological technical field.
Background technology
Bird flu (Avian influenza, AI) is a kind of poultry and the infectious disease of wild fowl caused by bird flu virus.Bird flu Virus, according to hemagglutinin (HA) and the difference of neuraminidase (NA), can be divided into 16 HA hypotypes and 9 NA hypotypes. High pathogenic avian influenza is the deadly infectious disease of the serious threat birds caused by some H5 or H7 subtype avian influenza virus.Some High pathogenic avian influenza virus can also cause the infection of people, morbidity, even dead.
Since 2003, the H5N1 subtype highly pathogenic avian influenza multiple countries and regions including China always are popular, Not only causing serious economic loss to aviculture, the health of the mankind in also serious threat.Except constantly strengthening and improving influenza Beyond monitoring, vaccine remains the important means of prevention and control AI.2005, it is extensive strong that China comes into effect for bird flu Property immunity policy processed, and achieve remarkable effect.Along with the continuous variation of virus, vaccine also updates Re-4 and Re-5 from Re-1, Re-6 and Re-7 up till now.All these vaccines are all six internal gene by PR8 (A/PR/8/34) and popular poison Two external gene restructuring of HA and NA of strain form.Due to the PR8 virus high-affinity to mammal, for safety Considering, these vaccines that all PR8 recombinate and come can only be made inactivated vaccine and use.Inactivated vaccine is mainly produced by induction of antibodies Protection body can be accelerated in antibody mediated immunity pressure lower variation speed from virus attack, virus from birth so that virus is more difficult to prevention And control.This patent provides a kind of new avian influenza vaccine and the diagnostic antigen preparation method planting poison used.Plant poison, as epidemic disease " seed " that Seedling produces, is the key point of production of vaccine.Supporting diagnostic antigen is that vaccine quality controls and vaccine using effect The necessary material evaluated, and planting poison is supporting hemagglutination test or the necessary material of hemagglutination inhibition test diagnostic antigen production.
Summary of the invention
This patent determine with first cold adaptation influenzae strain virus A/Ann Arbor/6/60 (AAca) six internal gene (PB2, PB1, PA, NP, M and NS) and the external gene (HA and NA) of epidemic isolates, by reverse genetics manipulation technology, Avian influenza vaccine and diagnostic antigen required kind poison.Reverse genetics manipulation technology refers to by certain or some artificial constructed plasmids, Transfect specific cell, produce a kind of technology of the desired virus obtained.Utilize cold adaptation influenzae strain virus A/Ann Arbor/6/60 (AAca) and Reverse Genetics prepare avian influenza vaccine and the required poison of planting of diagnostic antigen has higher safety, And keeping the advantages such as titer is high, matching is strong, attenuated vaccine or the inactivated vaccine of preparation are safe and reliable, can produce relatively after immunity Strong immunity, it is possible to the popular and propagation of preventing bird flu effectively, reduces the economic loss that primary disease causes, reduces human health Threat, there is important public health meaning, have broad application prospects.
This patent determines first prepares six internal gene sequences of required viral backbone during avian influenza vaccine with Reverse Genetics Row.
Detailed description of the invention
Below by embodiment, further illustrate technical scheme, but protection scope of the present invention is not limited to this.
The recombiant plasmid of expression A/Ann Arbor/6/60 (AAca) six internal gene of virus described in embodiment is moved by China Thing health preserves with epidemiology center construction, and 293T cell is purchased from QbioGene company;Liposome Lipofectamine2000 Purchased from Invitrogen company.
Embodiment 1
The construction method of restructuring H5 subtype avian influenza virus (rH5/AAca), comprises the steps:
1, synthetic and six internal gene of clone A/Ann Arbor/6/60 (AAca)
PB2, PB1, PA, NP, M, NS gene order (SEQ ID NO.1~NO.6) specified according to the present invention, adopts By the method for synthetic, insert it in bi-directional expression vector (can simultaneously transcribe generation viral RNA and mRNA), Prepare pH-PB2, pH-PB1, pH-PA, pH-NP, pH-M, pH-NS plasmid.
2, the clone of H5 subtype avian influenza virus surface gene
Amplification H5 subtype avian influenza virus HA and NA surface gene, and HA gene is carried out molecular modification, remove and H5 The multiple basic amino acids at HA protein cleavage site that subtype avian influenza virus pathogenicity is relevant so that it is obtain low pathogenicity fowl The characterization of molecules of influenza virus (will-PLRERRRKR-sport-PQRETR-), inserts it in bi-directional expression vector, Prepare pH-mHA and plasmid pH-NA.
3, the restructuring packaging of H5 subtype avian influenza virus and qualification
Express 6 internal gene recombinant expression plasmids of A/Ann Arbor/6/60 (AAca) virus, with expression H5 hypotype fowl Influenza virus HA and NA gene recombination plasmid, through liposome Lipofectamine 2000 cotransfection 293T cell.Will transfection Cell is inoculated in 10 age in days SPF Embryo Gallus domesticus, every embryo 0.1mL, two embryos of each sample inoculation through allantoic cavity, puts 35 DEG C and cultivates extremely 72h, collects allantoic fluid, and the standard recommended with International Office of Epizootics (OIE) carries out blood clotting (HA) and blood clotting suppression (HI) examination Test identifying virus.HI positive allantoic fluid, the 2nd generation allantoic fluid passed on Embryo Gallus domesticus extract RNA, RT-PCR amplification HA and NS genetic fragment checks order.Expand without the RNA PCR of reverse transcription.RT-PCR amplification and sequencing result show, save The virus rescued is restructuring H5 subtype avian influenza virus, without the RNA PCR of reverse transcription without amplified band.Obtain restructuring disease The named rH5/AAca of poison.
4, the enrichment procedure of virus needed for production of vaccine
With physiological saline solution 1: 10000 times dilution rH5/AAca virus, inoculate 10 age in days SPF Embryo Gallus domesticus, 0.1mL/ through allantoic cavity Embryo, the survival chick embryo allantoic liquid after results cultivation 72h, measure HA titer, virus allantoic fluid HA titer is 29, and aseptic It is qualified to check.
5, the virus inactivating method needed for production of vaccine
By addition formalin in the allantoic fluid of results to final concentration 0.2%, 2-8 DEG C of inactivation 48h, shake up once every 2h.Go out Living after 48h, each virus sample 10 pieces of Embryo Gallus domesticus of inoculation, every embryo 0.1mL, mensuration HA titer after hatching 72h, without coagulation An allantoic fluid blind passage generation again.The second filial generation is still judged to virus complete inactivation without coagulation.Result virus allantoic fluid Embryo Gallus domesticus passes on 2 times All coagulation without producing, inactivation is completely.
6, the quality testing of inactivated vaccine
Prepared rH5/AAca strain oil emulsion inactivated vaccine by the method for " veterinary biological product code " and carried out the aseptic examination of vaccine Test, physical behavior, safety detection.Indices meets the regulation of " veterinary biological product code ".
7, the immuning effect test of vaccine
50 21 age in days SPF chickens are randomly divided into 5 groups, often group 10.1-4 group intramuscular inoculation quality testing is qualified RH5/AAca avian influenza vaccine, immunizing dose is respectively 0.05,0.1,0.3,0.5mL/ only, the 5th group is blank group, Isolated rearing.After immunity 2 weeks and 3 weeks, blood sampling measured H5 subtype avian influenza virus antibody horizontal.Within after immunity 3 weeks, use homology H5 subtype highly pathogenic avian influenza virus counteracting toxic substances, it is determined that the immune protective effect (table 1) of vaccine.
The result of the test that affects of immune efficacy is shown by the different immunizing doses of H5 subtype avian influenza virus inactivated vaccine, is developed Vaccine immunity dosage be that 0.1mL/ only just can make vaccinated flock within 3 weeks after immunity, be obtained with the protection viral to H5.From From the point of view of antibody generation level, the antibody horizontal of 0.3mL/ immunizing dose group chicken is apparently higher than 0.1mL group, and 0.3mL group resists Body remained stable rises.Multiple comparisons shows, 0.3 is not notable (P > 0.05) with 0.5mL group antibody titer change difference, Illustrate under similarity condition, to select 0.3mL/ dose inoculation can reach effect of preferably preventing epidemic.
Table 1 is recombinated the immuning effect test of H5 subtype avian influenza virus oil emulsion inactivated vaccine
Note: * denominator represents test chicken number, molecule represents dead chicken number.
8, H5 subtype avian influenza virus is as the method for diagnostic antigen
The enrichment procedure of H5 subtype avian influenza virus is with step 4.The enrichment procedure of H5 subtype avian influenza virus is with step 4, inactivation Method is with step 5.Carry out hemagglutination inhibition test with this inactivation of viruses and detect the immune effect of vaccine (HI antibody titer) matched, As shown in step 7.
SEQUENCE LISTING
<110>China Animal Health and Epidemiology Center
<120>avian influenza vaccine and the diagnostic antigen preparation method planting poison used
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 2341
<212> DNA
<213> Influenza virus
<400> 1
agcgaaagca ggtcaattat attcaatatg gaaagaataa aagaactacg gaatctgatg 60
tcgcagtctc gcactcgcga gatactaaca aaaaccacag tggaccatat ggccataatt 120
aagaagtaca catcagggag acaggaaaag aacccgtcac ttaggatgaa atggatgatg 180
gcaatgaaat atccgattac agccgacaag aggataacag aaatgattcc tgagagaaat 240
gagcaagggc aaactctatg gagtaaaatg agtgatgccg gatcggatcg tgtgatggta 300
tcacctctgg ctgtgacatg gtggaataga aatggaccaa tgacaagtac ggttcattat 360
ccaaaaatct acaaaactta ttttgagaaa gtcgaaaggt taaaacatgg aacctttggc 420
cctgttcatt ttagaaacca agtcaaaata cgccgaagag ttgacataaa tcctggtcat 480
gcagacctca gtgccaagga ggcacaggat gtaatcatgg aagttgtttt ccctaacgaa 540
gtgggggcca ggatactaac gtcggaatcg caattaacaa taaccaaaga gaaaaaagaa 600
gaactccagg attgcaaaat ttcacctttg atggttgcgt acatgttaga gagagaactt 660
gtccgaaaaa cgagatttct cccagttgct ggtggaacaa gcagtgtgta catcgaagtg 720
ttgcacttga ctcaaggaac atgctgggaa cagatgtaca ctccaggtgg agaagtgagg 780
aatgatgatg ttgatcaaag tctaattatt gcagccagga gcatagtgag aagagcagca 840
gtatcagcag atccactagc atctttattg gagatgtgcc acagcacaca gattggcggg 900
acaaggatgg tggacattct taggcagaac ccaacagaag agcaagctgt ggaaatatgc 960
aaagctgcaa tgggactgag gatcagctca tccttcagtt ttggcgggtt cacatttaag 1020
agaacaagcg gatcatcagt caagagagag gaagaagtgc ttacgggcaa tcttcaaaca 1080
ttgaaaataa gggtgcatga gggatacgag gagttcacaa tggttgggaa aagggcaaca 1140
gctatactca gaaaagcaac caggagattg attcagctga tagtgagtgg aagagacgaa 1200
cagtcgatag ccgaagcaat aattgtggcc atggtatttt cacaagaaga ttgtatgata 1260
aaagcagtta gaggtgatct gaatttcgtt aatagggcaa atcagcgatt gaatcccatg 1320
catcaacttt taagacattt tcagaaggat gctaaagtgc tttttcaaaa ttggggaatt 1380
gaacatatcg acaatgtgat gggaatgatt ggggtattac cagacatgac tccaagcaca 1440
gagatgtcaa tgagaggggt aagagtcagc aaaatgggcg tagatgaata ctccagcgcg 1500
gagagagtag tggtgagcat tgaccggttt ttgagagttc gagaccaacg aggaaatgta 1560
ctactatctc ctgaggaggt cagtgaaaca cagggaacag agaaactgac aataacttac 1620
tcatcgtcaa tgatgtggga gattaatggc cctgagtcag tgttggtcaa tacctatcag 1680
tggatcatca gaaactggga aactgttaaa attcagtggt ctcagaatcc tacaatgcta 1740
tacaataaaa tggaatttga gccatttcag tctttagttc ctaaggccat tagaggccaa 1800
tacagtgggt ttgttaggac tctattccaa caaatgaggg atgtacttgg gacatttgat 1860
accacccaga taataaaact tcttcccttt gcagccgccc caccaaagca aagtagaatg 1920
caattctctt cattgactgt gaatgtgagg ggatcaggaa tgagaatact tgtaaggggc 1980
aattctccta tattcaacta caacaagacc actaagagac taacaattct cggaaaggat 2040
gctggcactt taactgaaga cccagatgaa ggcacatctg gagtggagtc cgctgttctg 2100
agaggattcc tcattctggg caaagaagat aggagatatg gaccagcatt aagcatcaat 2160
gaactgagta accttgcgaa aggagaaaag gctaatgtac taattgggca aggagacgtg 2220
gtgttggtaa tgaaacgaaa acggaactct agcatactta ctgacagcca gacagcgacc 2280
aaaaggattc ggatggccat caattaatgt tgaatagttt aaaaacgacc ttgtttctac 2340
t 2341
<210> 2
<211> 2341
<212> DNA
<213> Influenza virus
<400> 2
agcgaaagca ggcaaaccat ttgaatggat gtcaatccga ccttactttt cttgaaagtt 60
ccagcgcaaa atgccataag tactacattc ccttatactg gagatcctcc atacagccat 120
ggaacaggaa caggatacac catggacaca gtcaacagaa cacatcaata ttcagaaaag 180
gggaagtgga caacaaacac ggaaactgga gcgcaccaac ttaacccaat tgatggacca 240
ctacctgagg acaatgaacc aagtggatat gcacaaacag actgcgtcct ggaagcaatg 300
gctttccttg aagaatccca cccaggaatc tttgaaaact cgtgtcttga aacgatggaa 360
gttattcaac aaacaagagt ggacaaactg acccaaggtc gtcagaccta tgattggaca 420
ttgaacagaa atcagccggc tgcaactgcg ctagccaaca ctatagaggt cttcagatcg 480
aatggcctga cagctaatga atcgggaagg ctaatagatt tcctcaagga tgtgatagaa 540
tcaatggata aagaggagat ggaaatcaca acacacttcc aaagaaaaag aagagtaaga 600
gacaacatga ccaagaaaat ggtcacacaa cgaacaatag gaaagaagaa gcaaagattg 660
aacaagagaa gctatctaat aagagcactg acattgaaca caatgactaa agatgcagag 720
agaggtaaat taaagagaag agcaattgca acacccggta tgcagatcag agggttcgtg 780
tactttgtcg aaacactagc gagaagtatt tgtgagaagc ttgaacagtc tgggcttccg 840
gttggaggta atgaaaagaa ggctaaactg gcaaatgttg tgcgaaaaat gatgactaat 900
tcacaagaca cagagctctc tttcacaatt actggagaca ataccaaatg gaatgagaat 960
caaaatcctc ggatgttcct ggcgatgata acatacatca caagaaatca acctgaatgg 1020
tttagaaacg tcctgagcat cgcacctata atgttctcaa ataaaatggc aagactaggg 1080
aaaggataca tgttcaaaag caagagcatg aagctccgaa cacaaatacc agcagaaatg 1140
ctagcaagta ttgacctgaa atactttaat gaatcaacaa gaaagaaaat cgaggaaata 1200
aggcctctcc taatagatgg cacagtctca ttgagtcctg gaatgatgat gggcatgttc 1260
aacatgctaa gtacagtctt aggagtctca atcctgaatc ttggacaaaa gaagtacacc 1320
aaaacaacat actggtggga cggactccaa tcctctgatg acttcgccct catagtgaat 1380
gcaccaaatc atgagggaat acaagcaggg gtggatagat tctacagaac ctgcaagcta 1440
gtcggaatca atatgagcaa aaagaagtcc tacataaata ggacagggac atttgaattc 1500
acaagctttt tctatcgcta tggatttgta gccaatttta gcatggagct gcccagcttt 1560
ggagtgtctg gaattaatga atcggctgat atgagcattg gggtaacagt gataaagaac 1620
aacatgataa acaatgacct tgggccagca acagcccaac tggctcttca actattcatc 1680
aaagactaca gatatacgta ccggtgccac agaggagaca cacaaattca gacaaggaga 1740
tcattcgagc taaagaagct gtgggggcaa acccgctcaa aggcaggact tttggtttcg 1800
gatggaggac caaacttata caatatccgg aatctccaca ttccagaagt ctgcttgaag 1860
tgggagctaa tggatgaaga ctatcagggg aggctttgta atcccctgaa tccatttgtc 1920
agtcataagg agattgagtc tgtaaacaat gctgtggtaa tgccagctca cggtccagcc 1980
aagagcatgg aatatgatgc tgttactact acacactcct ggatccctaa gaggaaccgc 2040
tccattctca acacaagcca aaggggaatt cttgaagatg aacagatgta tcagaagtgt 2100
tgcaatctat tcgagaaatt cttccctagc agttcgtaca ggagaccagt tggaatttcc 2160
agcatggtgg aggccatggt gtctagggcc cggattgatg cacggattga cttcgagtct 2220
ggacggatta agaaagagga gttcgctgag atcatgaaga tctgttccac cattgaagag 2280
ctcagacggc aaaaatagtg aatttagctt gtccttcatg aaaaaatgcc ttgtttctac 2340
t 2341
<210> 3
<211> 2233
<212> DNA
<213> Influenza virus
<400> 3
agcgaaagca ggtactgatt cgaaatggaa gattttgtgc gacaatgctt caatccgatg 60
attgtcgagc ttgcggaaaa agcaatgaaa gagtatggag aggatctgaa aatcgaaaca 120
aacaaatttg cagcaatatg cactcacttg gaagtatgct tcatgtattc agattttcat 180
ttcatcaatg agcaaggcga gtcaataata gtagagcttg atgatccaaa tgcacttttg 240
aagcacagat ttgaaataat agagggaaga gatcgcacaa tggcctggac agtagtaaac 300
agtatttgca acactacagg agctgagaaa ccgaagtttc tgccagattt gtatgattac 360
aaggagaata gattcatcga gattggagtg acaaggaggg aagtccacat atactatctt 420
gaaaaggcca ataaaattaa atctgagaag acacacatcc acattttctc attcactggg 480
gaagaaatgg ccacaaaggc cgactacact ctcgatgagg aaagcagggc taggatcaaa 540
accagactat tcaccataag acaagaaatg gctagcagag gcctctggga ttcctttcat 600
cagtccgaaa gaggcgaaga aacaattgaa gaaagatttg aaatcacagg gacaatgcgc 660
aggctcgccg accaaagtct cccgccgaac ttctcctgcc ttgagaattt tagagcctat 720
gtggatggat tcgaaccgaa cggctacatt gagggcaagc tttctcaaat gtccaaagaa 780
gtaaatgcta aaattgaacc ttttctgaaa acaacaccaa gaccaattag acttccggat 840
gggcctcctt gttctcagcg gtccaaattc ctgctgatgg atgctttaaa attaagcatt 900
gaggacccaa gtcacgaagg agagggaata ccactatatg atgcgatcaa gtgtatgaga 960
acattctttg gatggaaaga accctatgtt gttaaaccac acgaaaaggg aataaatcca 1020
aattatctgc tgtcatggaa gcaagtactg gcagaactgc aggacattga gaatgaggag 1080
aagattccaa gaaccaaaaa catgaagaaa acgagtcagc taaagtgggc acttggtgag 1140
aacatggcac cagagaaggt agactttgac gactgtagag atgtaagcga tttgaagcaa 1200
tatgatagtg atgaacctga attaaggtca ctttcaagct ggatccagaa tgagttcaac 1260
aaggcatgcg agctgaccga ttcaatctgg atagagctcg atgagattgg agaagatgtg 1320
gctccaattg aacacattgc aagcatgaga aggaattact tcacagcaga ggtgtctcat 1380
tgcagagcca cagaatatat aatgaagggg gtatacatta atactgcctt gcttaatgca 1440
tcctgtgcag caatggacga tttccaacta attcccatga taagcaaatg tagaactaaa 1500
gagggaaggc gaaagaccaa tttatatggt ttcatcataa aaggaagatc tcacttaagg 1560
aatgacaccg acgtggtaaa ctttgtgagc atggagtttt ctctcactga cccaagactt 1620
gagccacaca aatgggagaa gtactgtgtt cttgagatag gagatatgct actaagaagt 1680
gccataggcc aggtgtcaag gcccatgttc ttgtatgtga ggacaaatgg aacatcaaag 1740
attaaaatga aatggggaat ggagatgagg cgttgcctcc ttcagtcact ccaacaaatc 1800
gagagtatga ttgaagccga gtcctctgtc aaggagaaag acatgaccaa agagtttttc 1860
aagaataaat cagaaacatg gcccattgga gagtccccca aaggagtgga agaaggttcc 1920
attgggaagg tctgcaggac tttattagcc aagtcggtat tcaatagcct gtatgcatct 1980
ccacaattag aaggattttc agctgaatca agaaaactgc ttcttgtcgt tcaggctctt 2040
agggacaatc ttgaacctgg gacctttgat cttggggggc tatatgaagc aattgaggag 2100
tgcctgatta atgatccctg ggttttgctt aatgcgtctt ggttcaactc cttcctaaca 2160
catgcattaa gatagttgtg gcaatgctac tatttgctat ccatactgtc caaaaaagta 2220
ccttgtttct act 2233
<210> 4
<211> 1566
<212> DNA
<213> Influenza virus
<400> 4
agcgaaagca gggtagataa tcactcactg agtgacatca aaatcatggc gtcccaaggc 60
accaaacggt cttatgaaca gatggaaact gatggggaac gccagaatgc aaatgaaatc 120
agagcatccg tcgggaagat gattggtgga attggacgat tctacatcca aatgtgcacc 180
gaacttaaac tcagtgatta tgaggggcgg ctgatccaga acagcttaac aatagagaga 240
atggtgctct ctgcttttga cgagaggagg aataaatatc tggaagaaca tcccagcgcg 300
gggaaggatc ctaagaaaac tggaggaccc atatacaaga gagtagatgg aaagtggatg 360
agggaactcg tcctttatga caaagaagaa ataaggcgaa tctggcgcca agctaataat 420
ggtgatgatg caacagctgg tctgactcac atgatgatct ggcattccaa tttgaatgat 480
acaacatacc agaggacaag agctcttgtt cgcaccggaa tggatcccag gatgtgctct 540
ttgatgcagg gttcgactct ccctaggagg tctggagccg caggcgctgc agtcaaagga 600
gttgggacaa tggtgatgga gttgataagg atgatcaaac gtgggatcaa tgatcggaac 660
ttctggagag gtgagaatgg gcggaaaaca aggaatgctt atgagagaat gtgcaacatt 720
ctcaaaggaa aatttcaaac agctgcacaa agagcaatga tggatcaagt gagagaaagc 780
cggaacccag gaaatgctga gatcgaagat ctcatctttc tggcacggtc tgcactcata 840
ttgagagggt cagttgctca caaatcttgt ctgcctgcct gtgtgtatgg acctgccgta 900
gccagtggct acgacttcga aaaagaggga tactctttag tagggataga ccctttcaaa 960
ctgcttcaaa acagccaagt atacagccta atcagaccga atgagaatcc agcacacaag 1020
agtcagctgg tgtggatggc atgcaattct gctgcatttg aagatctaag agtatcaagc 1080
ttcatcagag ggaccaaagt aatcccaagg gggaaacttt ccactagagg agtacaaatt 1140
gcttcaaatg aaaacatgga tactatggga tcaagtactc ttgaactgag aagcaggtac 1200
tgggccataa ggaccagaag tggaggaaac actaatcaac agagggcctc tgcaggtcaa 1260
atcagtgtac aacctacgtt ttctgtgcaa agaaacctcc catttgacaa accaaccatc 1320
atggcagcat tcactgggaa tgcagaggga agaacatcag acatgagggc agaaatcata 1380
aggatgatgg aaggtgcaaa accagaagaa gtgtccttcc aggggcgggg agtcttcgag 1440
ctctcggacg aaaaggcaac gaacccgatc gtgccctctt ttgacatgag taatgaagga 1500
tcttatttct tcggagacaa tgcagaggag tacgacaatt aaggaaaaaa tacccttgtt 1560
tctact 1566
<210> 5
<211> 1027
<212> DNA
<213> Influenza virus
<400> 5
agcgaaagca ggtagatatt gaaagatgag tcttctaacc gaggtcgaaa cgtacgttct 60
ctctatcatc ccgtcaggcc ccctcaaagc cgagatcgca cagagacttg aagatgtctt 120
tgctgggaaa aacaccgatc ttgaggctct catggaatgg ctaaagacaa gaccaatcct 180
gtcacctctg actaagggga ttttgggatt tgtattcacg ctcaccgtgc ccagtgagcg 240
aggactgcag cgtagacgct ttgtccaaaa tgccctcaat gggaatgggg atccaaataa 300
catggacaga gcagttaaac tgtatagaaa gcttaagagg gagataacat tccatggggc 360
caaagaaata gcgctcagtt attctgctgg tgcacttgcc agttgtatgg gcctcatata 420
caacaggatg ggggctgtga ccactgaagt ggtcttaggc ctggtatgtg caacctgtga 480
acagattgct gactcccagc ataggtctca taggcaaatg gtgacaacaa ccaatccact 540
aataagacat gagaacagaa tggttctggc cagcactaca gctaaggcta tggagcaaat 600
ggctggatcg agtgagcaag cagcagaggc catggaggtt gctagtcagg ccaggcaaat 660
ggtgcaggca atgagagtta ttgggactca tcctagctcc agtgctggtc taaaaaatga 720
tcttcttgaa aatttgcagg cctatcagaa acgaatgggg gtgcagatgc aacgattcaa 780
gtgaccctct tgttgttgcc gcgagtatca ttgggatctt gcacttgata ttgtggattc 840
ttgatcatct ttttttcaaa tgcatttatc gcttctttaa acacggtctg aaaagagggc 900
cttctacgga aggagtacca gagtctatga gggaagaata tcgaaaggaa cagcagagtg 960
ctgtggatgc tgacgatagt cattttgtca gcatagagct ggagtaaaaa actaccttgt 1020
ttctact 1027
<210> 6
<211> 890
<212> DNA
<213> Influenza virus
<400> 6
agcgaaagca gggtgacaaa gacataatgg atcctaacac tgtgtcaagc tttcaggtag 60
attgcttcct ttggcatgtc cgcaaacaag ttgcagacca agaactaggt gatgccccat 120
tccttgatcg gcttcgccga gatcagaagt ccctaagggg aagaggcagt actctcggtc 180
tgaacatcga aacagccacc cgtgttggaa agcagatagt ggagaggatt ctgaaggaag 240
aatccgatga ggcacttaaa atgaccatgg cctccgcacc tgcttcgcga tacctaactg 300
acatgactat tgaggaaatg tcaagggact ggttcatgct aatgcccaag cagaaagtgg 360
caggccctct ttgtatcaga atggaccagg caatcatgga taagaacatc atattgaaag 420
cgaatttcag tgtgattttt gaccggctag agaccctaat attactaagg gctttcaccg 480
aagcgggagc aattgttggc gaaatttcac cattgccttc tcttccagga catactaatg 540
aggatgtcaa aaatgcaatt ggggtcctca tcggaggact tgaatggaat gataacacag 600
ttcgagtctc taaaactcta cagagattcg cttggagaag cagtgatgag aatgggagac 660
ctccactcac tccaaaatag aaacggaaaa tggcgagaac aattaggtca aaagttcgaa 720
gaaataagat ggctgattga agaagtgaga cacaaattga agataacaga gaatagtttt 780
gagcaaataa catttatgca agccttacag ctactatttg aagtggaaca agagataaga 840
actttctcgt ttcagcttat ttaatgataa aaaacaccct tgtttctact 890

Claims (5)

1. with Reverse Genetics and cold adaptation influenzae strain viral backbone, artificial constructed influenza virus, the kind poison produced as avian influenza vaccine.
Plant poison the most as claimed in claim 1, it is characterized in that, described bird flu virus PB2, PB1, PA, NP, M, NS gene order and SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5, SEQ ID NO.6 similarity (similarity) are higher than 95%.
3. the kind poison described in claim 2, for avian influenza vaccine or the production of supporting diagnostic antigen.
4. the kind poison described in claim 2, for H5 subtype avian influenza vaccine or the production of supporting diagnostic reagent.
5. the kind poison described in claim 2, for H7 subtype avian influenza vaccine or the production of supporting diagnostic reagent.
CN201510502806.5A 2015-04-02 2015-08-17 Avian influenza vaccine and the diagnostic antigen preparation method planting poison used Pending CN106190993A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510152425 2015-04-02
CN2015101524259 2015-04-02

Publications (1)

Publication Number Publication Date
CN106190993A true CN106190993A (en) 2016-12-07

Family

ID=57453094

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510502806.5A Pending CN106190993A (en) 2015-04-02 2015-08-17 Avian influenza vaccine and the diagnostic antigen preparation method planting poison used

Country Status (1)

Country Link
CN (1) CN106190993A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107064499A (en) * 2017-03-15 2017-08-18 青岛蔚蓝生物制品有限公司 Avian influenza virus nucleoprotein antigen epitope polypeptide and its colloid gold test paper box

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1810961A (en) * 2006-02-22 2006-08-02 中国人民解放军军事医学科学院微生物流行病研究所 Recombinant influenza virus and its prepn and application
CN101780275A (en) * 2009-01-21 2010-07-21 中国农业科学院哈尔滨兽医研究所 Development of H5N1 subtype avian influenza cold-adaption attenuated live vaccines and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1810961A (en) * 2006-02-22 2006-08-02 中国人民解放军军事医学科学院微生物流行病研究所 Recombinant influenza virus and its prepn and application
CN101780275A (en) * 2009-01-21 2010-07-21 中国农业科学院哈尔滨兽医研究所 Development of H5N1 subtype avian influenza cold-adaption attenuated live vaccines and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
叶艺: ""A型流感病毒冷适应株的拯救及免疫原性的初步研究"", 《中国优秀硕士学位论文全文数据库(电子期刊)医药卫生科技辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107064499A (en) * 2017-03-15 2017-08-18 青岛蔚蓝生物制品有限公司 Avian influenza virus nucleoprotein antigen epitope polypeptide and its colloid gold test paper box
CN107064499B (en) * 2017-03-15 2019-06-18 青岛蔚蓝生物制品有限公司 Avian influenza virus nucleoprotein antigen epitope polypeptide and its colloid gold test paper box

Similar Documents

Publication Publication Date Title
US10808229B2 (en) High titer recombinant influenza viruses with enhanced replication in vero cells
CN101472941B (en) High titer recombinant influenza viruses for vaccine
US10172934B2 (en) High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs
KR102080914B1 (en) Influenza virus mutants and uses therefor
US10246686B2 (en) Influenza virus replication for vaccine development
CN102304495A (en) Recombinant influenza virus capable of expressing HA (hemagglutinin) protein with high efficiency and preparation method and application thereof
CN108913701B (en) Method for improving multiplication titer of H7N9 subtype avian influenza vaccine strain
CN101780275A (en) Development of H5N1 subtype avian influenza cold-adaption attenuated live vaccines and application thereof
US20240010995A1 (en) Recombinant influenza viruses with stabilized na
US20220202927A1 (en) Recombinant influenza viruses with stabilized ha for replication in eggs
US11390649B2 (en) Influenza virus replication for vaccine development
CN108018300A (en) Distinguish immune and infection animal H7 subtype avian influenza vaccine strains and its preparation method and application
KR101835989B1 (en) Recombinant influenza virus to form cross-protection against multiple subtypes h3 and h7 of influenza viruses and vaccine comprising the same
KR101879936B1 (en) Novel H5N9 recombinant influenza virus and vaccine composition comprising the same
EP3715459B1 (en) H9 avian influenza vaccine strain which differentiates infected from vaccinated animals, and preparation method therefor
CN106190993A (en) Avian influenza vaccine and the diagnostic antigen preparation method planting poison used
CN101947317B (en) Large-scale preparation method of H5N1 avian influenza virus-like particle vaccines
KR20110131735A (en) Recombinant swine influenza a virus comprising the gene of a/korea/cj01/09 and a/puerto rico/08/34, and the swine influenza a virus vaccine comprising the same
CN104109655B (en) Kind of malicious preparation method needed for H7 subtype avian influenzas vaccine and diagnostic reagent
CN108103084A (en) Distinguish immune and infection animal H5 subtype avian influenza vaccine strains and its preparation method and application
RU2606019C1 (en) Vaccine influenza virus strain a/17/hongkong/2014/8296 (h3n2) for preparing live influenza intranasal vaccine for adults and children
US11214799B2 (en) HA-specific influenza virus attenuated vaccine comprising mutations in segment 7, and uses therefor
CN111269895B (en) Influenza a virus attenuated strain and application thereof as framework virus and vaccine
KR101857863B1 (en) Novel H5N9 recombinant influenza virus and vaccine composition comprising the same
KR101481986B1 (en) Live vaccine protecting against pathogenic avian influenza H5N1 and use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20161207

WD01 Invention patent application deemed withdrawn after publication